6 Dimensions Capital, L.P. 3
3 · Fulcrum Therapeutics, Inc. · Filed Jul 17, 2019
Insider Transaction Report
Form 3
6 Dimensions Capital, L.P.
10% Owner
Holdings
Series B Preferred Stocks
→ Common Shares (441,071 underlying)
Footnotes (1)
- [F1]The Series B Preferred Stock is convertible into Common Stock on 7:1 basis into the number of shares shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date.